To study phenotypic and functional characteristics of hepatic lymphocytes in patients with viral hepatitis or other liver related diseases.
ID
Source
Brief title
Condition
- Hepatic and hepatobiliary disorders
- Viral infectious disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
To phenotypically and functionally analyze liver and peripheral T cells in
patients with viral hepatitis and other liver diseases in order to get more
insight in immune system in the liver. Patients with viral hepatitis will be
compared with patients with a non-viral liver related disease.
Secondary outcome
-
Background summary
The mechanism of developing chronic hepatitis B and chronic hepatitis C, rather
than clearing acute infection, is not fully understood but is likely
multifactorial. Both chronic hepatitis B and C infection are associated with
impairment of the innate and adaptive immune responses and are associated with
narrow and weak T cell responses. The function of T cells in viral hepatitis
has largely been obtained by studying low numbers of peripheral blood T cells.
However, as hepatitis C and hepatitis B are hepatotrophic viruses,
virus-specific T cells accumulate in the human liver. Due to different
homeostatic circumstances and antigen environment in the target organ, residing
T cells may have altered functional characteristics and phenotype. As such
little is known about general and virus-specific immune responses in the
liver.
The aim of this study is to investigate the T cell immune system in the liver
which could provide insights into mechanisms of failure of viral control and/or
the development liver damage.
Study objective
To study phenotypic and functional characteristics of hepatic lymphocytes in
patients with viral hepatitis or other liver related diseases.
Study design
This is an interventional study with a once-only intervention of blood
collection performed in patients that undergo a liverresection or
transplantation. Of the resected specimen 5-15 gram of liver tissue, redundant
for pathological/histological investigation, will be used for analysis.
Intervention
Patients that are included in the study will donate 5 tubes of 9 ml blood once
only 1-2 weeks before surgery.
Study burden and risks
Potential physical discomfort associated with participation are the burden of
in total 69 ml of blood samples that will be taken once-only. These samples
will be taken when the patient is admitted to hospital and awaiting surgery.
The liverspecimen used for this study will by no means alter or influence
surgery procedures or outcome. Only tissue redundant for pathologic examination
will be used (this tissue had to be removed as part of the surgery).
Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
Patients between 18-65 year old that undergo a liverresection.
Exclusion criteria
Unwillingness to donate blood
Co-infection with HIV (if known)
(a HIV test is not required for participation in the study)
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL38694.018.11 |